DARE - Daré Bioscience, Inc.

-

$undefined

N/A

(N/A)

Daré Bioscience, Inc. NASDAQ:DARE Daré Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's health. The company's mission is to identify, develop and bring to market a diverse portfolio of differentiated therapies that expand treatment options, improve outcomes and facilitate convenience for women, primarily in the areas of contraception, vaginal health, sexual health, and fertility.

Location: | Website: www.darebioscience.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

17.71M

Cash

16.41M

Avg Qtr Burn

-2.515M

Short % of Float

0.47%

Insider Ownership

1.62%

Institutional Own.

7.10%

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
XACIATO (DARE-BV1) Details
Bacterial infection

Approved

Quarterly sales

Ovaprene® Details
Contraceptive

Phase 3

Update

Sildenafil Cream, 3.6% Details
Sexual desire disorder, Sexual dysfunction

Phase 3

Initiation

Phase 2

Initiation

DARE-PDM1 Details
Primary dysmenorrhea

Phase 1

Update

DARE-PTB1 Details
Preterm birth

Phase 1

Initiation

IND

Submission